vimarsana.com

Latest Breaking News On - Prnewswire pharming groupnv - Page 1 : vimarsana.com

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan

/PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the first patient has been enrolled.

JapanTokyoLondonCity ofUnited kingdomAmsterdamNoord hollandNetherlandsUnited statesCanadaAustraliaAmericaHirokazu kaneganeClaire dobbsEthan metelenisHeather robertson

Pharming Group N.V.: Pharming Group reports second quarter and first half 2023 financial results

Pharming Group N.V.: Pharming Group reports second quarter and first half 2023 financial results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

CanadaUnited kingdomAmsterdamNoord hollandNetherlandsIsraelUnited statesLondonCity ofJapanAustraliaAmericaAustralianDutchCanadianJapanese

Pharming Group reports second quarter and first half 2023 financial results

RUCONEST® business performed strongly in 2Q 2023; continue to anticipate low single digit annual revenue growth Strong start to U.S. Joenja® launch during 2Q.

CanadaLondonCity ofUnited kingdomJapanAustraliaNetherlandsUnited statesIsraelAmsterdamNoord hollandAmericaAustralianDutchCanadianJapanese

Pharming Group N.V.: Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board

Pharming Group N.V.: Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

MassachusettsUnited statesSouth carolinaBelgiumUniversity of south carolinaCharlestonNetherlandsAmsterdamNoord hollandLondonCity ofUnited kingdomBostonBelgianAmericaPaul sekhri

Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board - Kineta (NASDAQ:KA), Aprea Therapeutics (NASDAQ:APRE)

LEIDEN, The Netherlands, July 18, 2023 /PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (NASDAQ:PHAR) announces today that the Board of Directors has nominated Dr. Richard Peters to

South carolinaUnited statesBostonMassachusettsUnited kingdomBelgiumLondonCity ofAmsterdamNoord hollandNetherlandsCharlestonUniversity of south carolinaAmericaBelgianRichard peters

vimarsana © 2020. All Rights Reserved.